178546-34-4

Basic information

• Product Name: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-
• Synonyms: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-;3-bromo-5-fluoro-2-hydoxybenzaldehyde
• CAS NO: 178546-34-4
• Molecular Formula: C₇H₄BrFO₂
• Molecular Weight: 219.0078632
• Mol File: 178546-34-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(178546-34-4)
• EPA Substance Registry System: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(178546-34-4)

Safety Data

• Hazardous Substances Data: 178546-34-4(Hazardous Substances Data)

Usage

General Description

Benzaldehyde, 3-bromo-5-fluoro-2-hydroxy- is an organic compound with the molecular formula C7H5BrFO2. It is a derivative of benzaldehyde, a common aromatic aldehyde. The compound contains a bromine and fluorine atom attached to the carbon ring, as well as a hydroxyl group. It is used in various organic synthesis processes and as a building block for the preparation of pharmaceuticals and fine chemicals. Additionally, it has potential applications in the field of medicinal chemistry and drug discovery.

Upstream product

• 347-54-6 5-fluoro-2-hydroxybenzaldehyde 
• 50-00-0 formaldehyd 
• 496-69-5 2-bromo-4-fluoro-phenol 
• 100-97-0 hexamethylenetetramine 

Downstream Products

• 1009093-60-0 3-bromo-5-fluoro-2-methoxybenzaldehyde 
• 913629-79-5 3-Bromo-5-fluoro-benzene-1,2-diol 
• 1009092-61-8 C₄₅H₆₂FN₅O₆ 
• 1009093-66-6 C₃₄H₄₆FN₃O₇ 
• 1009093-65-5 C₂₅H₃₆BrFN₂O₅ 
• 1009093-63-3 C₂₁H₃₁BrFNO₅Si 
• 1009093-64-4 C₁₅H₁₇BrFNO₅ 
• 1009093-62-2 C₁₁H₁₁BrFNO₄ 
• 1009093-61-1 C₈H₉BrFNO₂ 
• 550998-61-3 7-bromo-5-fluoro-1-benzofuran-2-carboxylic acid 

Relevant articles and documents

Imidazo ring PAR4 antagonist and medical applications thereof

The invention relates to an imidazo ring compound represented by formula (I) or formula (II), or a pharmaceutically acceptable salt or ester or solvate thereof. The compound disclosed by the inventioncan be used for preparing medicines for preventing or treating thromboembolic diseases.

2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN DERIVATIVES 774

The present invention relates to compounds of formula (I), wherein R1 is heteroaryl or heterocyclyl, optionally substituted;R2 is C1-4alkyl, heterocyclyl, C1-4alkylaryl, C1-4alkylheteroaryl, carbocycl

NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE

[From equivalent EP1710233A1] The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, halo-lower alkyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, arylalkenyl, aryloxy-lower alkyl, heteroaryl, heteroaryl-lower alkyl, etc; R3, R4, R5 and R6 are each hydrogen, halogen, cyano, lower alkyl, halo-lower alkyl, lower alkoxy, hydroxy, aryl, etc; provided that at least one of R3, R4, R5 and R6 is other than hydrogen. Compound (I) of the present invention shows a potent adenosine A2A receptor antagonistic activity, and are useful for treating or preventing a disease mediated by adenosine A2A receptors such as motor function disorders, depression, anxiety disorders, cognitive function disorders, cerebral ischemia disorders, restless legs syndrome and the like.